In this report: Amarin Corp. (NASDAQ:AMRN), Netflix (NASDAQ:NFLX) and Aegon (NYSE:AEG).
Amarin Corp. (NASDAQ:AMRN) gained over 6 percent on Friday after the company announced that the Food and Drug Administration has approved its AMR101 marketing application and that it has set an action date of July 26th 2012. The company’s CEO Joseph Zakrzewski stated “We are very pleased with the FDA’s acceptance for filing of our AMR101 NDA submission as it is a significant achievement in the development of what we believe is a next generation Omega-3 based triglyceride lowering therapy”. Amarin currently trades at $7.08 per share.
Netflix (NASDAQ:NFLX) dropped anther 6.7 percent on Friday after the company’s announcement earlier this week that it plans to raise $400 million by issuing debt and stock. The company also warned investors that it could report a loss for 2012 due to a significant loss in the number of customers after its recent decision to split up its online streaming service from its DVD-by-mail service. The announcements were followed by a number of analysts who slashed their price targets on Netflix. Today’s loss marks a third straight day that the company has sank into the red. The company currently trades at $63.86 per share.
Aegon (NYSE:AEG) fell over 1.8 percent on Friday after the company was downgraded by analysts at Goldman Sachs. The firm lowered its rating on the Dutch insurer to ‘Neutral’ from ‘Buy’ which pushed the company’s stock lower to its current price of $3.67 per share.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL